<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658828"><TermName>Apidra</TermName><TermPronunciation>(uh-PEE-druh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the laboratory. Apidra gets into the blood faster than insulin when it is injected under the skin before or shortly after a meal. It is a type of therapeutic insulin. Also called insulin glulisine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726151" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Apidra&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726150" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Apidra&quot;" language="es" id="_4"/><SpanishTermName>Apidra</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para controlar la cantidad de azúcar en la sangre de pacientes de diabetes mellitus. Es una forma de la hormona insulina que se produce en el laboratorio. Apidra llega más rápido a la sangre que la insulina cuando se inyecta debajo de la piel antes o muy poco después de una comida. Es un tipo de insulina terapéutica. También se llama insulina glulisina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-03-30</DateFirstPublished></GlossaryTerm>
